04/12/2024
3:23 PM | 10x Genomics (Filer)
| Form PRE 14A | |
03/25/2024
4:15 PM | 10x Genomics (Issuer)
McAnear Justin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:16 PM | 10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:17 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
6:02 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:40 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024
6:19 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
02/22/2024
5:59 PM | 10x Genomics (Subject)
Hindson Benjamin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024
6:06 PM | 10x Genomics (Subject)
McAnear Justin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
3:20 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:33 PM | 10x Genomics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/09/2024
7:35 AM | 10x Genomics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/31/2024
1:08 PM | 10x Genomics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/29/2024
10:43 AM | 10x Genomics (Subject)
BAILLIE GIFFORD & CO (Filed by)
| Form SC 13G/A | |
01/18/2024
3:49 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
5:08 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
8:00 AM | 10x Genomics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
3:17 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
3:19 PM | 10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
4:43 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
4:09 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/08/2023
3:37 PM | 10x Genomics (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G/A | |
11/27/2023
5:16 PM | 10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:18 PM | 10x Genomics (Issuer)
Wilbur James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:15 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:15 PM | 10x Genomics (Issuer)
McAnear Justin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
3:25 PM | 10x Genomics (Subject)
Hindson Benjamin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
3:25 PM | 10x Genomics (Subject)
McAnear Justin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
3:29 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
3:30 PM | 10x Genomics (Issuer)
Wilbur James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
5:08 PM | 10x Genomics (Subject)
Wilbur James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023
3:22 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
3:33 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:43 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
4:15 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/24/2023
4:08 PM | 10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
4:08 PM | 10x Genomics (Issuer)
Wilbur James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
4:09 PM | 10x Genomics (Issuer)
McAnear Justin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
4:11 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
4:11 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
4:31 PM | 10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The World's First "$20 Trillion Drug?" (Ad) One small biotech holds the key to a revolution in treating Alzheimer's disease.
Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech.
Our research proves that anyone who gets in today could see gains as high as 113,000%! Get the name of the stock here >>> |
07/21/2023
4:32 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
1:21 PM | 10x Genomics (Subject)
Hindson Benjamin J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2023
5:26 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2023
3:38 PM | 10x Genomics (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G/A | |
07/10/2023
9:20 AM | 10x Genomics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
06/16/2023
4:45 PM | 10x Genomics (Issuer)
ROBERTS BRYAN E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:37 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:38 PM | 10x Genomics (Issuer)
Kosaraju Sridhar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:40 PM | 10x Genomics (Issuer)
Mammen Mathai (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:41 PM | 10x Genomics (Issuer)
Popovits Kimberly J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:42 PM | 10x Genomics (Issuer)
STUELPNAGEL JOHN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:43 PM | 10x Genomics (Issuer)
SULIMAN SHEHNAAZ (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:51 PM | 10x Genomics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
4:48 PM | 10x Genomics (Subject)
Saxonov Serge (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
5:32 PM | 10x Genomics (Issuer)
STUELPNAGEL JOHN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/25/2023
4:48 PM | 10x Genomics (Issuer)
McAnear Justin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/25/2023
4:49 PM | 10x Genomics (Issuer)
Wilbur James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/25/2023
4:49 PM | 10x Genomics (Issuer)
Hindson Benjamin J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
6:51 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
4:28 PM | 10x Genomics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2023
3:35 PM | 10x Genomics (Issuer)
Saxonov Serge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2023
4:35 PM | 10x Genomics (Subject)
Mammen Mathai (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
